ECM News in brief, February 4, 2011

04 Feb 2011

ITALY

Philogen launches in Milan

Swiss-Italian biotech company Philogen launched a Eu58.05m IPO on Thursday via Banca IMI and UBS.

The deal will sell a maximum of 10.7 million shares, of which 8.9 million are new and 1.8 million are existing shares. If all the shares are sold, the IPO ...

Please take a trial or subscribe to access this content.

Contact our subscriptions team to discuss your access: subs@globalcapital.com

Or sign up for a trial to gain full access to the entire site for a limited period.

Free Trial

Corporate access

To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: subs@globalcapital.com or find out more online here.

Oops, something went wrong

We're sorry but at the moment we can't load this data